Literature DB >> 23363058

Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11β-hydroxylase inhibition.

Silvia Gobbi1, Qingzhong Hu, Matthias Negri, Christina Zimmer, Federica Belluti, Angela Rampa, Rolf W Hartmann, Alessandra Bisi.   

Abstract

Imidazolylmethylflavones previously reported by us as aromatase inhibitors proved to be able to interact with aldosterone synthase (CYP11B2), a cytochrome P450 enzyme involved in the biosynthesis of the mineralcorticoid hormone aldosterone, and were used to obtain a pharmacophore model for this enzyme. Here, in the search for potential ligands for CYP11B2 and the related CYP11B1, a virtual screening of a small compounds library of our earlier synthesized aromatase inhibitors was performed and, according to the results and the corresponding biological data, led to the design and synthesis of a series of xanthones derivatives carrying an imidazolylmethyl substituent in position 1 and different substituents in position 4. Some very potent inhibitors were obtained; in particular, the 4-chlorine derivative was active in the low nanomolar or subnanomolar range on CYP11B2 and CYP11B1, respectively, proving that xanthone can be considered as an excellent scaffold, whose activity can be directed to different targets when appropriately functionalized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363058     DOI: 10.1021/jm301844q

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

Review 1.  CYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents.

Authors:  Lina Yin; Qingzhong Hu
Journal:  Nat Rev Urol       Date:  2013-11-26       Impact factor: 14.432

Review 2.  Recent progress in pharmaceutical therapies for castration-resistant prostate cancer.

Authors:  Lina Yin; Qingzhong Hu; Rolf W Hartmann
Journal:  Int J Mol Sci       Date:  2013-07-04       Impact factor: 5.923

3.  Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors.

Authors:  Muhammad Akram; Watcharee Waratchareeyakul; Joerg Haupenthal; Rolf W Hartmann; Daniela Schuster
Journal:  Front Chem       Date:  2017-12-19       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.